Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

“It’s a really exciting time, not just for NWEH, but also for the future of clinical trials in the UK. If successful, this ...

That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...

Trump has nominated Dr Jay Bhattacharya, a 56-year-old physician and health economist at Stanford University School of ...

Advanz won a temporary reprieve in September after the General Court of the European Union ordered a suspension of the EC's ...

Celebrating 10 years as the definitive platform for the NK community, the flagship Innate Killer Summit will unite ...

Returning to Boston in March, the 8th Gene Therapy Development Summit, formerly known as the Gene Therapy for Rare Disorders ...

Significant breakthroughs in CNS biology, coupled with innovative neuroscience technologies and a more supportive regulatory ...

The European Commission has cleared use of CDK4/6 inhibitor Kisqali (ribociclib) to reduce the risk of recurrence in patients with stage 2 or 3, HR-positive/HER2-negative early breast cancer, based on ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...

New guidance from health technology assessment (HTA) agency NICE backs the use of Wainzua (eplontersen) to treat stage 1 or 2 ...